BackTable / Innovation / Podcast / Episode #42
Prescribing Personalized Nutrition: Defining Digital Therapeutics
with Dominik Burziwoda and Dr. Torsten Schröder
In this episode, Dr. Diana Velazquez-Pimentel interviews Dominik Burziwoda and Dr. Torsten Schröder about their experience with starting Perfood, a digital therapeutics company that focuses on individualized nutrition changes as a means to treat chronic disease.
BackTable, LLC (Producer). (2022, December 23). Ep. 42 – Prescribing Personalized Nutrition: Defining Digital Therapeutics [Audio podcast]. Retrieved from https://www.backtable.com
Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs. Follow the button below to claim your credits on CMEfy.
Stay Up To Date
Dominik Burziwoda is the CEO and co-founder of Perfood GmbH.
Dr. Torsten Schröder
Dr. Torsten Schröder is the chief medical officer and co-founder of Perfood GmbH.
Dr. Diana Velazquez-Pimentel
Dr. Diana Velazquez-Pimentel is practicing physician and an NHS Clinical Entrepreneur in London.
The co-founders discuss their backgrounds and interests. For Dr. Schröder, this was clinical medicine and biomedical research. On the other hand, Dominik had prior experience with finance, law and e-commerce. Their combination of skills made it possible to establish Perfood as a startup and run successful clinical trials. Perfood seeks to empower consumers to learn more about their own glycemic reactions that result from different types of foods in their diet. The components of the product include a continuous glucose monitor and access to an app that will make dietary recommendations with the goal of lowering a patient’s glycemic index. This idea was spurred by the recognition of a link between blood glucose and various chronic diseases, as well as a lack of access to nutritional therapy.
We discuss the true meaning of a “digital therapeutic,” which is a software (which has been clinically evaluated and regulated) that can induce a treatment effect. With Perfood, the intended treatment effect is to help patients modify their lifestyle and lower blood glucose levels. Due to Germany’s centralized healthcare system, Perfood can be prescribed by any physician and patients will be fully reimbursed for the cost. So far, it has been approved in Germany for treatment and prevention of migraines. Dr. Schröder emphasizes that patients who experience the most success with Perfood are people who are motivated and able to make changes to their diet. The company aims to conduct more clinical trials that explore nutrition as a treatment for diabetes, neurodegenerative diseases, chronic inflammatory diseases, and malignancy. Perfood takes a patient-first approach by collaborating with patient advocacy groups and soliciting feedback from early users. Perfood is also exploring new markets in the United States and looking to partner with institutions to start pilot projects.
A Digital Health Application Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Proof-of-Concept Data from a Retrospective Cohort Study:
Mobi Health News:
Exit and Outcomes:
Digital Therapeutics Alliance:
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.